Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape
Abstract Hematopoietic stem cell transplantation (HSCT) is common practice today for life threatening malignant and non‐malignant diseases of the blood and immune systems. Umbilical cord blood (UCB) is rich in hematopoietic stem cells (HSCs) and is an attractive alternative to harvesting HSCs from b...
Main Authors: | Carla Dessels, Marco Alessandrini, Michael Sean Pepper |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.17-0244 |
Similar Items
-
Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01) -
Improving engraftment and immune reconstitution in umbilical cord blood transplantation
by: Robert eDanby, et al.
Published: (2014-02-01) -
Umbilical Cord Blood Banking and Transplantation : A short review
by: Salam Alkindi, et al.
Published: (2011-11-01) -
Umbilical cord blood quality and quantity: Collection up to transplantation
by: Seyed Hadi Mousavi, et al.
Published: (2019-01-01) -
Umbilical cord blood transplantation
by: Hong Hoe Koo, et al.
Published: (2012-07-01)